...查看全文
美股滚雪球2022-07-22 14:13
CNS药物领域不错的公司:$Xenon制药(XENE)$ &$Intra-cellular(ITCI)$ 被收购的概率比较大。
$恒瑞医药(SH600276)$查看全文
chuminhua2021-10-05 10:48
10月4日,在Xenon Pharmaceuticals宣布在研药物XEN1101用于局灶性癫痫成年患者的辅助治疗的IIb期研究达到其主要疗效终点后,该公司的股票在周一翻了一番。
X-TOLE试验随机选抽取了325名局灶性癫痫的成年人,让他们接受三种每天一次的XEN1101剂量中的一种或安慰剂。结果显示,与安慰剂相比,这...查看全文
andrewmed2021-03-10 09:27
文章来源:“凯莱英药闻”微信公众号
2021年3月8日,Xenon Pharmaceuticals宣布与西奈山伊坎医学院合作,以推进一项研究者发起的概念验证性、双盲、随机、平行设计、安慰剂对照2期临床试验,评估XEN1101用于治疗重度抑郁症(MDD)和快感缺失。
为了测试XEN1101与安慰剂相比在MDD和重度快感...查看全文
智通财经APP获悉,10月4日(周一)美股盘初,截至北京时间22:02,专注于神经学的生物制药公司Xenon Pharmaceuticals(XENE.US)涨74.78%,报27.265美元。早前,该公司公布了2b期X-Tole临床试验的积极结果,该临床试验评估了XEN1101的临床有... 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-15 AccNo: 0001564590-18-005873 Size: 63 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 内部交易: 2018-03-12,CEO,PIMSTONE SIMON N. ,期权,10288普通股, $3.77
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-13 AccNo: 0001564590-18-005484 Size: 99 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8....
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-13 AccNo: 0001564590-18-005484 Size: 99 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8....
$Xenon Pharmaceuticals Inc.(XENE)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-03-07 AccNo: 0001564590-18-004754 Size: 209 KB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-07 AccNo: 0001564590-18-004750 Size: 9 MB 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-07 AccNo: 0001564590-18-004719 Size: 244 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-07 AccNo: 0001564590-18-004719 Size: 244 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-07 AccNo: 0001564590-18-004712 Size: 170 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Xenon Pharmaceuticals Inc.(XENE)$ 8-K - Current report Filed: 2018-03-07 AccNo: 0001564590-18-004719 Size: 244 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接